Inside India newsletter: India weighs a tax cut to win over foreign investors. Will it work?
Foreign investors are losing their appetite for Indian equities, with their holdings touching an all-time low of 14%.
International news in seven languages
Topic
Foreign investors are losing their appetite for Indian equities, with their holdings touching an all-time low of 14%.
The Halloween edition of “SNL” Weekend Update saw a cameo by Ben Marshall’s Pennywise as well as some jabs at President Trump’s recent obsession with candidates’ posteriors. “Even Vice President JD Vance came out and said that he was jealous that President Trump has never complimented his butt. What the hell is going on! Your […]
As Washington and Tehran send mixed signals, analysts say trust remains a key obstacle to any deal.
Bangladesh’s proposed cyber law targets AI-generated fakes, but critics warn broad provisions on rumours, defamation and disinformation could revive censorship and threaten online free expression, even as victims need protection.
As Israel approaches a consequential parliamentary election amid renewed violence in the occupied West Bank, Yedioth Ahronoth Senior Journalist Ben-Dror Yemini offers a critical assessment of Benjamin Netanyahu's political prospects, the limits of military escalation and the shifting relationship between national security and electoral legitimacy. Since October 7, 2023 "Netanyahu is not popular anymore," Yemini argues, identifying the Hamas-led attacks as a decisive turning point in the Israeli prime minister's public standing.
Donald Trump said he hasn't decided whether the execution of the Fort Hood shooter will be livestreamed, after the Pentagon announced it would do so. The plan has been criticized by both Republicans and Democrats.
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Ennismore is Accor's best shot at gaining a U.S. foothold. But ambition isn't a funding plan, and CEO Sébastien Bazin hasn't yet said where the capital to expand Ennismore would come from, such as an IPO.
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.